However, those with tier 2 PTEN variants had lower lifetime risks of kidney, endometrial, thyroid, and colorectal cancers, as well as melanoma compared with those with tier 1 PTEN variants (eFigure 4 in Supplement 1). Here, PTEN is linked to melanoma.